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SUMMARY
Cryopyrin (CIAS1, NLRP3) and ASC are components of the inflammasome, a multiprotein complex
required for caspase-1 activation and cytokine IL-1βproduction. CIAS1 mutations underlie
autoinflammation characterized by excessive IL-1β secretion. Disease-associated cryopyrin also
causes a program of necrosis-like cell death in macrophages, the mechanistic details of which are
unknown. We find that patient monocytes carrying disease-associated CIAS1 mutations exhibit
excessive necrosis-like death by a process dependent on ASC and cathepsin B, resulting in spillage
of the proinflammatory mediator HMGB1. Shigella flexneri infection also causes cryopyrin-
dependent macrophage necrosis with features similar to the death caused by mutant CIAS1. This
necrotic death is independent of caspase-1 and IL-1β, and thus independent of the inflammasome.
Furthermore, necrosis of primary macrophages requires the presence of Shigella virulence genes.
While similar proteins mediate pathogen-induced cell death in plants, this report identifies cryopyrin
as an important host regulator of programmed pathogen-induced necrosis in animals, a process we
term pyronecrosis.
INTRODUCTION
The CATERPILLER family (Harton et al., 2002) (CLR, also known as NLR) is comprised of
proteins involved in the regulation of innate immunity (Inohara and Nunez, 2003; Martinon
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and Tschopp, 2005). Functionally similar to the evolutionarily conserved Toll-like receptors
(TLRs), increasing evidence suggests that CLRs may serve as intracellular molecules that sense
pathogen-derived products (Hoffmann and Reichhart, 2002; Poltorak et al., 1998). Significant
attention has been focused one CLR family member, cryopyrin, which is encoded by the gene
CIAS1. CIAS1 is mutated in a trio of dominantly inherited periodic fevers: FCAS (familial cold
autoinflammatory syndrome), MWS (Muckle-Wells syndrome), and CINCA/NOMID (chronic
infantile neurological cutaneous and articular syndrome/neonatal onset multisystemic auto-
inflammatory disease), which are proposed to represent a continuum of severity for a single
condition, CIAS1-associated periodic syndrome (CAPS) (Aksentijevich et al., 2002; Feldmann
et al., 2002; Hoffman et al., 2001a, 2001b).
Recent investigations have highlighted an essential role for IL-1β in the development of
mutant-CIAS1-associated periodic fevers. Mutant CIAS1/NLRP3 causes elevated levels of
spontaneous and induced IL-1β both in vitro and in vivo. Indeed, FCAS, MWS, and CINCA/
NOMID have all been successfully treated with daily doses of the IL-1β receptor antagonist
Anakinra (Kineret) (Goldbach-Mansky et al., 2006; Hawkins et al., 2004; Hoffman et al.,
2004). Cryopyrin participates in the regulation of IL-1β through involvement in a
multimolecular complex called the inflammasome (Agostini et al., 2004). This complex, which
also includes ASC (Apoptotic Speck protein containing a CARD) and TUCAN, promotes
activation of caspase-1/ICE. In turn, caspase-1 then cleaves pro-IL-1β to produce mature
IL-1β, which is released from the cell. Mutations in cryopyrin result in the hyperactivation of
this pathway, causing excessive IL-1β production and the severe episodes of inflammation.
The functions of cryopyrin in the immune system are not limited to autoinflammatory disorders.
Several recent reports have established cryopyrin as an important adaptor capable of organizing
the inflammasome to elicit IL-1β release in response to bacterial, viral, and other
proinflammatory stimuli (Kanneganti et al., 2006a, 2006b; Mariathasan et al., 2006; Martinon
et al., 2006; Sutterwala et al., 2006). However, it is not yet known if the protein has additional
biologic functions in the containment of pathogens.
Clues regarding an additional role for cryopyrin in response to pathogen may lie within its
makeup. Cryopyrin consists of an amino-terminal pyrin domain, a central NACHT (NAIP,
CIITA, HET-E, TP1) domain, and seven carboxy terminal LRRs (leucine-rich repeats). This
architecture is conserved in plants, where similar proteins comprise a subfamily of disease-
resistant (R) proteins called NB-LRRs (Ausubel, 2005; Chisholm et al., 2006). The NB-LRR
proteins respond to microbial pathogen by eliciting a hypersensitive death response in infected
cells, thus resulting in elimination of the pathogen (Greenberg et al., 1994; Nimchuk et al.,
2003). Similarly, one mammalian host response to microbial pathogen is macrophage/
monocyte necrotic-like death, which can lead to pathogen elimination, but also to exacerbated
inflammation and sepsis (Krysko et al., 2006). The participation of cryopyrin in initiating
necrosis has been hinted at previously, as cryopyrin-deficient macrophages demonstrate
reduced levels of cell death in response to the Gram-positive Staphylococcus bacteria
(Mariathasan et al., 2006). However, the molecular players that mediate such a process and the
mechanism of this form of cell death have yet been defined.
We report here that cryopyrin and ASC are required for a process of necrotic-like cell death.
We furthermore expand the capabilities of cryopyrin by demonstrating that it mediates both
the IL-1β and cell death response to a Gram-negative bacterium, S. flexneri, resulting in cellular
necrosis and the exacerbation of inflammation. The observation that Shigella-induced cell
death is independent of caspase-1 and IL-1β indicates that this process occurs independently
of inflammasome formation. It further suggests that disease-associated cryopyrin represents a
hyperactive form of the protein, while the function of the normal counterpart is to induce cell
death only upon stimulation with bacteria or other pathogens.
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Expression of Disease-Associated CIAS1 Mutants Induces a Necrotic-like Cell Death
Mutations in CIAS1 are associated with the periodic fever syndromes FCAS, MWS, and
CINCA/NOMID. Adenoviral constructs were transduced at a moi = 1 to promote efficient
exogenous expression of wild-type CIAS1 or CIAS1 containing mutations encoding the disease-
associated amino acid changes A439V or R260W (Figure S1A in the Supplemental Data
available with this article online). A fourth construct encoding LacZ was designed as a negative
control. Expression of the disease-associated mutants dramatically decreased cell viability in
the THP-1 monocytic cell line in three separate assays: the XTT assay (Figure 1A), trypan blue
(Figure S1B), and Viaprobe (Figure S1C). Staurosporine was used to induce apoptosis in all
of these assays. To determine the mode of cryopyrin-induced cell death, we examined the
activation of caspase-3. During apoptosis, caspase-3 undergoes activating cleavage. In turn,
caspase-3 cleaves PARP and other downstream substrates. Neither caspase-3 nor PARP were
cleaved in cells expressing a disease-associated mutant cryopyrin, though both were cleaved
in staurosporine-treated cells (Figure 1B). Further, pretreatment of cells with the pan-caspase
inhibitor (zVAD-fmk) failed to abrogate cell death (Figure 1C). These results indicate that
mutant-cryopyrin-induced cell death does not require or proceed via caspase activation. DNA
fragmentation, another hallmark of apoptosis, was not observed in mutant-cryopyrin-
expressing cells (Figure 1D), though the positive control, staurosporine, induced DNA
fragmentation in a caspase-dependent manner (Figure 1D and Figure S2A). Moreover, in
contrast to apoptotic cells, mutant-cryopyrin-expressing cells did not demonstrate an increase
in mitochondrial membrane permeability at two time points (summarized in Figure 1E, and
shown in detail in Figure S2B). Finally, electron microscopy shows that mutant-cryopyrin-
expressing cells exhibit morphological features consistent with necrosis. Cells expressing
mutant cryopyrin demonstrate several of these features: (1) degradation of the plasma
membrane, (2) dysmorphic/swollen mitochondria, and (3) lack of chromatin condensation
(Figure 1F, middle panel). Staurosporine caused a typical apoptotic morphology (Figure 1F,
right panel). Taken together, our results support previous data indicating that disease-associated
variants of cryopyrin induce cell death consistent with necrosis (Fujisawa et al., 2006).
Disease-Associated Cryopyrin Mutants Induce Enhanced IL-1β Release, but Cell Death Is
Independent of Caspase-1 and IL-1β Signaling
CIAS1-associated periodic fevers are characterized by excessive IL-1β production. To explore
the mechanism by which disease-associated cryopyrin causes cell death, we first determined
if this process is dependent on caspase-1 or IL-1β. In agreement with previous observations,
substantially more IL-1β was released from cells expressing mutant cryopyrin than cells
expressing wild-type cryopyrin (Figure 2A) (Agostini et al., 2004; Dowds et al., 2004). IL-18
is also regulated by caspase-1, and levels of IL-18 are greatly induced by disease-associated
cryopyrin (Figure 2B). Treatment with YVAD-CHO, a specific peptide inhibitor of caspase-1,
abrogated mutant-cryopyrin-induced release of IL-1β and IL-18 (Figures 2A and 2B.).
However, while YVAD-CHO successfully blocked IL-1β and IL18, mutant-cryopyrin-induced
cell death was unaffected (Figure 2C). Kineret (Anakinra), an IL-1 receptor antagonist (IL-1Ra)
also failed to diminish mutant-cryopyrin-induced cell death (Figure 2D). To assure that the
concentration of Kineret was adequate to block the biologic function of IL-1β, we measured
its effect on IL-1β-mediated induction of IL-8 (Figure 2E). Even at a concentration a log lower
than that used in the cell viability assay (Figure 2D), the induction of IL-8 by IL-1β was
abolished by Kineret. Together, these results demonstrate that mutant-cryopyrin-induced cell
death occurs independently of caspase-1 activity and IL-1β-mediated signaling. As previously
reported, inhibition of cathepsin B with 50 μM Ca-074-Me substantially blocked cell death
caused by disease-associated cryopyrin but had no effect on staurosporine-induced death
(Fujisawa et al., 2006). Of note, Figure 1C shows that the pan-caspase inhibitor caused a slight
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reversal of disease variant cryopyrin-mediated cell death. This slight improvement in viability
may be attributed to cross inhibition of cathepsin B by the zVAD peptide (Schotte et al.,
1999).
Disease-Associated Mutant-Cryopyrin-Induced Cell Death Is ASC Dependent
To further explore the mechanism by which disease-associated CIAS1 causes cell death, the
role of ASC was examined. Short hairpin RNA molecules (shRNAs) were designed to promote
the degradation of ASC mRNA (shASC). A control shRNA with a mutated target ASC
sequence was also prepared (shCntrl). These shRNAs were incorporated into retrovirus and
stably transduced into THP-1 cells, resulting in stable reduction of both ASC protein and
mRNA (Figures 3A and 3B). A second ASC shRNA generated the same results (data not
shown). Consistent with a role for ASC in the inflammasome, shASC diminished spontaneous
production of IL-1β induced by wild-type and mutant cryopyrin (Figure 3C). More importantly,
shASC reverted cell death induced by the A439V disease-associated cryopyrin mutant (Figure
3D). These results demonstrate that ASC is required for mutant-cryopyrin-induced cell death
as well as IL-1β production in monocytic/macrophage cell types.
Disease-Associated Cryopyrin Mutants Induce HMGB1 Release
HMGB1 is emerging as an important therapeutic target for sepsis, cancer, and other conditions.
Normally maintained as a nuclear factor within the healthy cell, HMGB1 takes on the role of
a strong proinflammatory factor when released from cells undergoing necrosis (Scaffidi et al.,
2002). This prompted us to examine the release of HMGB1 in the presence of disease-
associated cryopyrin. As measured by western analysis, HMGB1 release from cells transduced
with the wild-type CIAS1-adenovirus is barely detectable, but a high level is released by cells
expressing either of two disease-associated forms of CIAS1 (Figure 4A). Though ASC is
essential for HMGB1 release (Figure 4B), caspase-1 activity is not (Figure 4C). HMGB1
release following the induction of apoptosis with staurosporine is not observed at the 6 hr time
point but is only observed 24 hr posttreatment. This is likely the consequence of secondary
necrosis caused by longer treatment time (Figure S2C). Collectively, the results presented in
Figures 3 and 4 suggest that mutant cryopyrin causes necrotic-like cell death and subsequent
HMGB1 release in an ASC-dependent but caspase-1-independent fashion.
LPS Induces Death of FCAS Patient Cells
We next sought to determine the effects of CIAS1 mutation on cell viability in peripheral blood
mononuclear cells (PBMCs) from FCAS patients with confirmed CIAS1 mutations. Samples
were obtained from patients with CIAS1 mutations who have not undergone anti-inflammatory
treatment. The endotoxin lipopolysaccharide (LPS) has been used by others to induce
monocytic cell death (Karahashi and Amano, 1998). LPS is also known to induce CIAS1
mRNA and protein expression, both of which are very low in resting mononuclear cells
(O’Connor et al., 2003). LPS challenge resulted in a dose-dependent decrease in cell viability
in patient PBMCs but not healthy controls, supporting the conclusions made from exogenous
expression of disease-associated cryopyrin (Figure 5A). As disease-associated cryopyrin
variants are generally accepted as gain-of-function mutants, properties observed with disease-
associated cryopyrin are expected to be observed with wild-type cryopyrin, either at a reduced
level or under stimulated conditions. While adenovirus with disease-associated CIAS1 caused
substantial cell death at moi = 1, transduction of adenovirus containing wild-type cryopyrin
into THP-1 cells also resulted in cell death when a higher moi was used (Figure 5B). These
findings prompted us to determine whether wild-type cryopyrin plays a role in cell necrosis
associated with bacterial pathogenesis.
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Shigella flexneri-Induced Cell Death Requires Cryopyrin and ASC, but Not Caspase-1
Necrosis of monocytes and macrophages is a documented response to pathogenic bacteria,
although proteins that control this process are not well defined (Golstein and Kroemer, 2007;
Zong and Thompson, 2006). Significant evidence indicates that Shigella causes a necrotic-like
cell death, although apoptosis has also been reported (Koterski et al., 2005; Nonaka et al.,
2003; Suzuki et al., 2005; Zychlinsky and Sansonetti, 1997). This led us to examine the
potential of wild-type cryopyrin to mediate necrosis in response to Shigella flexneri. Stable
reduction of cryopyrin protein in THP-1 cells was achieved utilizing retroviral-transduced
shRNAs specific for CIAS1, which caused a near-ablation of targeted gene expression (Figure
6A). The induction of IL-1β by S. flexneri was nearly abolished in cryopyrin-deficient cells as
measured by ELISA, providing a biologic assay to assure that the CIAS1 shRNA caused the
intended biologic effect (Figure 6B). More importantly, S. flexneri-induced death was
substantially abrogated in shCIAS1 cells (Figure 6C). The presence of shCIAS1 did not affect
staurosporine-induced cell death, indicating specificity of cryopyrin for S. flexneri-induced
death. To confirm that cryopryin-mediated cell death requires ASC, we tested the ability of
Shigella to elicit cell death and IL-1β in ASC-deficient THP1 cells. As expected, both cell
death and IL-1β release were substantially abrogated in the shASC cells (Figures 6D and 6E).
To examine the physiologic importance of these results, we utilized macrophages isolated from
wild-type and CIAS1 gene-ablated mice. In wild-type bone marrow-derived macrophages,
Shigella caused a 2.5- to 3-fold increase in cell death compared to uninfected macrophages.
However, in CIAS1−/− macrophages, Shigella failed to initiate cell death above the level of
uninfected cells (Figure 6F). Moreover, the level of IL-1β secretion was reduced approximately
15-fold in peritoneal macrophages from CIAS1−/− mice (Figure 6G). The requirement of
CIAS1 for both cell death and IL-1β release in response to S. flexneri establishes wild-type
cryopyrin as a critical host adaptor capable of responding to a Gram-negative bacterial
pathogen. In contrast, bone marrow-derived macrophages isolated from mice lacking caspase-1
demonstrated no differential cell death response to S. flexneri (Figure 6H), though caspase-1
remained essential for IL-1β activation (Figure 6I). These results indicate that cryopyrin and
ASC, but not caspase-1, are required for S. flexneri-induced macrophage necrosis.
Cryopyrin-dependent cell death is not observed in cells infected with another intracellular
bacteria, Salmonella typhi, thus indicating that the role of cryopyrin cannot be generalized to
all intracellular bacteria (Figure S3) (Mariathasan et al., 2006). To assess if cryopyrin-induced
cell death is caused by virulence factors expressed by S. flexneri, we compared avirulent,
plasmid-cured S. flexneri (BS103) and the virulent parental strain (2457T). The former lacks
a 230 kb virulence plasmid that encodes the invasion plasmid antigens IpaB, IpaC, and IpaD.
These antigens are essential for S. flexneri virulence and entrance into the host cell (Menard
et al., 1993). Immunoblot analysis was used to confirm the plasmid-cured Shigella strain lacks
the IpaB protein, while this protein is detected in the parental strain (Figure 6J, left panel, inset).
Cell death was assayed at two (2 and 4 hr) different time points. At both time points, virulent
Shigella (2457T) caused cell death, and this process was reduced in macrophages lacking the
CIAS1 gene (Figure 6J, right and left panels). As expected, when macrophages were infected
with the plasmid-cured BS103 strain, cell death is reduced by >80%. This residual level of cell
death was not affected by the absence of CIAS1. These results indicate that virulence factors
expressed by S. flexneri cause CIAS1-dependent cell death.
Cryopyrin Mediates Shigella-Induced Necrotic-like Cell Death with Properties Similar to
Mutant-Cryopyrin-Induced Death
Having established that cryopyrin was essential for Shigella-mediated cell death, we sought to
determine the nature of cell death and whether it was consistent with the necrotic-like death
induced by mutant cryopyrin. Infection of shCTRL THP-1 cells with S. flexneri for 6 hr resulted
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in cell death with features morphologically consistent with necrosis (Figure 7A, compare 7Ai
and 7Aii). To verify that the necrotic cells contain bacteria, we performed electron microscopy
at an earlier time point (2 hr after infection) when the cell morphology is less fragmented. Cells
with a negative control shRNA that are infected with bacteria demonstrate the initial loss of
cytoplasm, indicating necrosis (Figure 7Aiii). In contrast, cellular morphology consistent with
cell death was not observed in shCIAS1 cells, despite the presence of several intracellular
Shigella bacteria (Figure 7Aiv). Next, we examined biochemical properties of cryopyrin-
initiated IL-1β and cell death response to Shigella. In contrast to the apoptotic control
staurosporine, Shigella-induced cell death did not result in the cleavage of PARP after 6 hr
(Figure 7B). Earlier reports have suggested that S. flexneri induces apoptosis in macrophages
at early time points, while necrosis is observed at later points (Zychlinsky et al., 1992; Koterski
et al., 2005). We observed that treatment with the pan-caspase inhibitor zVAD slightly
diminished cell death after 2 hr of infection, but not after 6 hr of infection. The caspase-1-
specific inhibitor YVAD had no effect. Attempts to inhibit cell death and IL-1β release with
glycine pretreatment, previously shown to reduce Shigella-induced apoptosis, were also
ineffective (Figure S4) (Edgeworth et al., 2002). However, the cathep-sin B inhibitor Ca-074-
Me substantially blocked cell death, further validating that mutant cryopyrin and Shigella-
induced necrosis occurred via the same pathway (Figure 7C). Although the caspase-1 inhibitor
YVAD failed to block cell death, it substantially abrogated both IL-1β and IL-18 in response
to Shigella in shCTRL cells, indicating that cell death is predominantly caspase-1, IL-1β, and
IL-18 independent (Figures 7D and 7E). As expected, shCIAS1 nearly abolished both IL-1β
and IL-18. Finally, Shigella-mediated cell death was associated with the release of HMGB1
(Figure 7F). In contrast, treatment with apoptosis-inducing staurosporine for 2 and 6 hr did not
cause HMGB1 release.
Thus, S. flexneri-induced death shared multiple characteristics associated with the necrotic-
like cell death observed with disease-associated cryopyrin, suggesting that this process is
mediated by cryopyrin and ASC and proceeds through cathepsin B independent of either
caspase-1 or IL-1β, resulting in HMGB1 release.
DISCUSSION
We report a necrotic-like cell death caused by disease-associated mutants of CIAS1, which is
dependent on ASC but not on caspase-1 or IL-1β. This process results in release of the
proinflammatory mediator HMGB1, which likely propagates the inflammatory response.
Additionally, we show that ASC and native, wild-type cryopyrin are required for S. flexneri-
induced cell death, which proceeds in a manner identical to that induced by disease-associated
cryopyrin. These results implicate cryopyrin as a crucial regulator of pathogen-induced
necrotic-like death, a process proposed to play an important role in the pathogenesis of a myriad
of infectious diseases, which we propose to call pyronecrosis.
From the perspective of cryopyrin-associated periodic fever, these results and the accumulated
data in the literature suggest that cryopyrin mutants directly regulate disease progression
through at least two distinct signaling pathways. It is known that cryopyrin participates in the
activation of caspase-1, the maturation of IL-1β, and subsequent hyperactivation of the
inflammatory process via an ASC-dependent process (Agostini et al., 2004). Previous reports
have indicated that disease-associated mutants demonstrate a gain-of-function phenotype with
respect to these properties leading to enhanced IL-1β release (Dowds et al., 2004). We report
a second gain-of-function, the induction of necrotic-like cell death. The manner of death is
particularly important. While it is generally believed that apoptotic cells die an orderly death
with minimal impact on inflammation, necrosis involves the spilling of cellular contents into
the environment, intensifying local inflammation and damaging neighboring cells (Krysko et
al., 2006). It is important to keep in mind that the IL-1 receptor antagonist Anakinra has been
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successfully used to treat patients suffering from CAPS, indicating that excessive IL-1β
production underlies disease. This would seem to suggest that the inflammasome function of
cryopyrin is solely responsible for periodic fever in these patients. However, given that necrosis
allows for the release of proinflammatory factors such as HMGB1, which in turn promote
further release of IL-1β, it is likely that cryopyrin-mediated cell death also contributes to disease
state in patients.
Both disease-associated cryopyrin expression and S. flexneri infection triggered the release of
HMGB1, a chromatin-associated protein released by necrotic cells. Once HMGB1 is released,
it acts as a potent danger indicator, inducing several proinflammatory cytokines by signaling
through the RAGE, TLR2, and TLR4 receptors to elicit a severe inflammatory response
(Andersson et al., 2000; Hori et al., 1995; Park et al., 2004). Serum HMGB1 is increased both
during endotoxin exposure in mice and in septic patients who succumbed to infection (Wang
et al., 1999). HMGB1 neutralization has been shown to significantly reduce inflammation and
improve survival in animal models of established sepsis (Yang et al., 2004). The release of
HMGB1 elicited by bacterial-induced cell death further supports the use of HMGB1
antagonists to reduce inflammation during sepsis.
The results shown here demonstrate a requirement for ASC in cryopyrin-induced cell death.
ASC was initially identified as a cytosolic protein aggregated into specks in myeloid cells
undergoing apoptosis and has since been implicated in several cell death pathways in
nonmyeloid cells (Masumoto et al., 1999). Functionally ASC is a bipartite adaptor protein
comprised of N-terminal pyrin domain (PD) and C-terminal CARD. It is proposed that these
domains each engage in homotypic interactions, thereby linking the PD of cryopyrin to the
CARD region of caspases. Constitutive interactions between several transfected disease-
associated cryopyrin mutants and ASC have been reported when overexpressed in a HEK293T
cells (Dowds et al., 2004). Overexpressed ASC has also been shown to interact with caspases-8
and-9, and several studies have implicated ASC in the progression of apoptosis. The concurrent
overexpression of a related protein, Ipaf, with ASC in HEK293T cells results in caspase-8-
dependent apoptosis, while overexpression of ASC alone induces caspase-9-mediated cell
death in HEK293 cells (Masumoto et al., 2003; McConnell and Vertino, 2000). These
observations suggest the involvement of apoptotic caspases in ASC-induced cell death in
nonmonocytic cells (Dowds et al., 2004; Masumoto et al., 2003; Wang et al., 2004). However,
coimmunoprecipitation experiments in monocytic THP-1 cells indicate that ASC/caspase
interaction is limited to caspase-1, suggesting that ASC is not involved in the initiation of
apoptotic caspases in these cells (Stehlik et al., 2003). Our results in a monocytic cell type
demonstrate that ASC is important in a necrotic-like cell death pathway that is caspase
independent.
The results here delineate an endogenous program of necrosis initiated by cryopyrin and ASC.
This pathway proceeds through cathepsin B, yet occurs independent of caspase-1, IL-1β, and
the inflammasome. Recently, ASC has also been implicated in the initiation of another rapid
form of inflammatory cell death called pyroptosis. In contrast to the necrosis initiated by
cryopyrin and ASC, pyroptosis requires caspase-1 activation by ASC following the
dimerization of ASC into speck-like pyroptosomes (Fernandes-Alnemri et al., 2007).
Pyroptosomes per se do not contain detectable cryopyrin; however, the role of cryopyrin in the
formation of this structure was not tested. This form of cell death has features of both apoptosis
and oncosis. Unlike the cryopyrin/ASC necrosis pathway described here, pyroptosis can be
blocked by exogenous caspase inhibitors; however, the requirement for cathepsin B has not
been investigated (Fernandes-Alnemri et al., 2007). The involvement of ASC in the induction
of both pyronecrosis and pyroptosis establish ASC as a key component in the host defense
arsenal to invading pathogens.
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Several recent reports establish cryopyrin as a pivotal regulator of IL-1 and IL-18 release to
both bacterial and viral challenges. Utilizing macrophages isolated from CIAS1−/− mice,
components of the immune response to Gram-positive bacteria such as Staphylococcus
aureus and Listeria monocytogenes, as well as Sendai and influenza viruses, have been shown
to require cryopyrin (Kanneganti et al., 2006a; Mariathasan et al., 2006). However, infection
with Gram-negative Salmonella typhimurium or Francisella tularensis elicits caspase-1
activation and IL-1β release in a cryopyrin-independent fashion (Mariathasan et al., 2005;
Sutterwala et al., 2006). Macrophage cell death induced by Salmonella and Francisella are
similarly unaffected by CIAS1 deficiency (Mariathasan et al., 2005). Alternate proteins mediate
the response to these pathogens. Ipaf, which participates in its own inflammasome, is
responsible for initiating inflammation in response to Salmonella typhimurium (Mariathasan
et al., 2004). It has been suggested that cryopyrin does not mediate the recognition of Gram-
negative bacteria. However, our results indicate that cryopyrin mediates both IL-1β release
and cell death in response to the Gram-negative bacteria S. flexneri in THP-1 cells and mouse
macrophages (Figure 7). Thus, cryopyrin mediates IL-1β processing and secretion in response
to specific Gram-positive and -negative bacteria.
Despite substantial progress made in understanding pathogen-induced host cell death, the
mechanisms governing Shigella-induced host cell death have not been conclusively delineated
(Haimovich and Venkatesan, 2006). This study illuminates a necrotic host cell-death pathway
detonated by Shigella requiring both cryopyrin and ASC. While the strain M90T (Serogroup
5) has been reported to induce both necrosis and caspase-1-dependent apoptosis (Francois et
al., 2000; Raqib et al., 2002; Zychlinsky et al., 1992), many others have observed caspase-1-
independent necrosis initiated by strains 2457T (Serogroup 2A), YSH6000 (Serotype 2A), and
now 12022 (Serogroup 2B) (Fernandez-Prada et al., 1997, 2000; Koterski et al., 2005; Nonaka
et al., 2003). These differences have been attributed to differences in species and infected cell
types, Shigella strains, duration and multiplicity of infection, and conclusions regarding the
nature of cell death drawn from incomplete methodology (Nonaka et al., 2003). The results
presented here verify and define cryopyrin and ASC as key components of a caspase-1-
independent mechanism by which Shigella induces necrosis and should do much to advance
the understanding of Shigella pathogenesis.
Further resolved is the putative involvement of caspase-1 in mediating Shigella-induced cell
death. Previous reports have suggested that the virulence factor IpaB is secreted by Shigella
via a type III secretion system upon contact with host cells and subsequently binds directly to
caspase-1 to induce cell death (Blocker et al., 1999; Chen et al., 1996; Menard et al., 1994).
Our results clearly demonstrate a caspase-1-independent pathway, as both caspase-1-specific
inhibitors and macrophages lacking caspase-1 were equally susceptible to Shigella-induced
cell death as wild-type controls, a result consistent with other reports (Suzuki et al., 2005). It
should be noted that Suzuki et al. observed an early apoptotic event requiring caspase-1, and
IpaB preceded a later necrotic event that occurs independent of caspase-1 or IpaB, and thus
both outcomes are possible. While we show here that cryopyrin and ASC are required for
Shigella-initiated necrosis, the activation of NF-κB and JNK in epithelial cell line following
Shigella infection has been reported to require the overexpression of NOD1/CARD4 (Girardin
et al., 2001). Although verification of this finding using primary epithelial cells from mice
lacking NOD1/CARD4 has not been performed to confirm the physiologic relevance of this
data, taken together, these data suggest that several CLR proteins might mediate different
aspects of the immune response to Shigella in a cell-type specific fashion.
In summary, we report that disease-associated cryopyrin mediates a form of necrotic-like cell
death that is replicated when normal monocytes encounter the bacterial pathogen S. flexneri.
These findings suggest that the gain-of-function mutant cryopyrin in patients might propagate
an inflammatory response without the normal stimulation caused by pathogens. These findings
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also show a parallel with pathogen-induced, NB-LRR-mediated cell death found in plants. A
long history of elegant studies in plants has shown that cell death is a major mechanism by
which plant R proteins mediate host response to multiple microbial pathogens (Belkhadir et
al., 2004). It will be important to determine if other NBD-LRR proteins also cause the induction
of cell death in myeloid and nonmyeloid cells, and if these proteins mediate both apoptotic and
necrotic death in a pathogen-specific fashion.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
THP-1 cells were purchased from American Type Culture Collection (ATCC) and cultured as
described previously (Williams et al., 2005). Anti-caspase-3 antibody was purchased from Cell
Signaling; anti-PARP, anti-ipaB, anti-Actin, and HRP-conjugated secondary antibodies from
Santa Cruz Biotechnology; anti-HMGB1 antibody from Abcam; anti-ASC antibody from
Immuno Diagnostic Oy; anti-Cryopyrin antibody from Alexis Biochemicals; Super Signal
ECL reagent from Bio-Rad; E. coli LPS from Chemicon. Detailed methods for preparation of
retroviral shuttle vectors, transduction, and sorting to generate THP-1 cell lines stably
expressing shRNA have been described (Taxman et al., 2006). The shRNA target sequences
are as follows: shASC-GCTCTTCAGTTTCACACCA, shCtrl-GCTCTTCctggcCACAC CA,
shCIAS-GGATGAACCTGTTCCAAAA. Stable expression of shRNA did not induce
interferon response as assessed by OAS1 expression (data not shown).
Generation of Recombinant Adenoviruses
Recombinant adenovirus expressing CIAS1 or LacZ was generated using Adeno-X Expression
System (Clontech). Briefly, genes were subcloned into pShuttle2 intermediate vector and
ligated into the modified type 5 human adenoviral genome vector Adeno-X following excision
with PI-Sce and I-Ceu enzymes. Recombinant adenovirus was then amplified in HEK293 cells
and purified using Adeno-X Virus Purification Kit (Clontech). Viral titers were determined by
UNC Viral Vector Core Facility (UNC-Chapel Hill).
Adenovirus Transduction of THP-1 Cells
THP-1 cells were aliquoted into Falcon 2059 polypropylene tubes at a density of 106/ml in
RPMI 1640 containing 10% FBS. After addition of adenovirus (moi = 1 unless otherwise
noted), cells were centrifuged at 2000 × g for 2 hr at 37°C. Immediately after centrifugation,
cells were resuspended and incubated at 5 × 105/ml following the addition of fresh RPMI 1640
containing 10% FBS.
XTT Assay
Cells were plated into 96-well plates at 20,000 cells per well 24 hr after adenovirus transduction.
Fifty microliters of serum-free media containing 25 μM phenazine methosulfate and 1 mg/ml
XTT was added to each well. Plates were read at 450 nM after 4 hr of incubation.
Mitochondrial Membrane Potential Staining
Cells were stained with tetramethylrhodamine ethyl ester, perchlorate (TMRE) for 25 min at
37°C at a final concentration of 5 nM. After staining, cells were rinsed in PBS, resuspended
in 0.5 ml PBS, and analyzed using a FACScan (Becton Dickinson) in FL2.
Immunoblotting
Immunoblots were performed as described previously (Williams et al., 2005). Cryopyrin was
immunoprecipitated with rabbit anti-CIAS-1 peptide IgG. Expression was confirmed by
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probing immunoblots with anti-CIAS1. HMGB1 blots were performed directly on culture
supernatants and developed as indicated.
Quantitative PCR
Total RNA was isolated, cDNA was reversed transcribed, and quantitative PCR was performed
using Absolute SYBR green mix (ABgene, UK) to assess ASC mRNA expression as described
(Taxman et al., 2006). Real-time values were standardized to the expression of 18 s rRNA and
normalized to 100 in control (untransduced) cells. Primers used for real-time PCR are as
follows: ASC-[AACCCAAGCAAGA TGCGGAAG, TTAGGGCCTGGAGGAGCAAG], 18
s-[CGGCTACCAC ATCCAAGG, GCTGCTGGCACCAGACTT].
Viaprobe and 7-AAD Cell Staining
Cells were collected and rinsed twice in cold PBS. Pellets were resuspended in 0.5 ml PBS
with 3 μl Viaprobe (Becton Dickinson) or 1 μl 7-AAD (BD PharMingen). Cells were incubated
in the dark for 15 min before analysis on a FACScan (BD).
Propidium Iodide Staining
Following treatment, cells were collected and pelleted via centrifugation. Pelleted cells were
fixed in 70% ethanol for a minimum of 2 hr, rinsed once in PBS, then resuspended in PBS
containing 1% Triton, 20 μg/ml propidium iodide (Sigma Chemical Co.), and 200 μg/ml RN-
ase A (QIAGEN). The cells were allowed to stain for 15 min or longer and then analyzed using
a FACScan (BD).
ELISA
THP1 samples were harvested 24 hr posttransduction and assayed with BD OptEIA Human
IL-1β ELISA Set (BD Biosciences) and Human IL-18 ELISA (MBL International). Mouse
samples were taken at indicated times postinfection and assayed with BD OptEIA Mouse
IL-1β ELISA Set (BD Biosciences).
Electron Microscopy
THP-1 cells were infected with adenoviruses at moi = 1 and fixed in 2% paraformaldehyde,
2.5% glutaraldehyde, in 0.15 M sodium phosphate (pH 7.4) 2 or 6 hr postinfection. Electron
microscopy was performed at the UNC Microscopy Services Laboratory.
Patient Cells
Two female patients (ages 62 and 71) with FCAS were included in the study. Both FCAS
patients had classic clinical presentation and met diagnostic criteria, as described previously
(Hoffman et al., 2001b). Neither FCAS subject was experiencing significant inflammatory
symptoms at the time of study, nor on regular anti-inflammatory medications. Two female
controls (ages 39 and 41) were studied simultaneously with the FCAS patients. However, one
control was later found to have significantly abnormal inflammatory responses and therefore
was not included. An additional four male controls aged 27–34 were subsequently studied.
PBMCs were isolated and prepared as previously described (Stack et al., 2005).
CIAS1 and Caspase-1-Deficient Mice
CIAS1−/− and Caspase-1−/− mice were described previously and were respectively produced
by Millenium Inc. and Dr. Richard Flavell, Yale University (Sutterwala et al., 2006). They
were backcrossed for a minimum of six generations to C57BL/6. Macrophages were obtained
by peritoneal lavage 5 days after intraperitoneal injection with 4% thioglycollate and cultured
in DMEM supplemented with 10% fetal calf serum and 50 μg/ml penicillin and streptomycin.
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Bone marrow macrophages were harvested from 6- to 8-week-old mice and cultured for 7 days
in 30% M-CSF conditioned media.
Bacterial Infections
Shigella flexneri strain 12022 was obtained from ATCC. 2457T and BS103 have been
described previously (Fernandez-Prada et al., 1997). THP-1 cells were cultured at 106/ml in
antibiotic-free RPMI. All samples were infected with S. flexneri or S. typhi bacteria at a moi
of 50 at 37°C for the indicated amount of time. Samples were centrifuged at 650 × g for 10
min immediately following addition of bacteria. Gentamicin (50 μg/ml) was added to cultures
2 hr postinfection.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Disease-Associated Cryopyrin Causes Necrotic-like Cell Death
(A) Cell viability is diminished in THP-1 cells expressing disease-associated CIAS1 mutants.
XTT reduction was measured 24 hr after adenoviral transduction.
(B) Mutant CIAS1-induced cell death does not cause caspase-3 or PARP cleavage.
Immunoblots for caspase-3 or its substrate PARP were performed on lysates made from cells
infected with the indicated adenoviral constructs or treated with staurosporine. Cleaved
caspase-3 and PARP are observed in staurosporine-treated cells but not in THP-1 cells
expressing wild-type or disease-associated A439V CIAS1.
(C) Incubation with 100 μM pan-caspase (zVAD-fmk) inhibitor does not substantially block
cell death.
(D) THP-1 cells expressing the R260W or A439V disease-associated mutant die without
exhibiting DNA fragmentation. DNA content was measured by PI staining followed by flow
cytometry. The percentage of cells with sub-G1 content, indicating the DNA fragmentation
characteristic of apoptosis, is shown.
(E) Disease-associated cryopyrin expression does not promote the loss of mitochondrial
membrane potential. THP-1 cells were treated as indicated. Mitochondrial membrane potential
was measured with the potential-sensitive dye TMRE. Data summarized here are shown in
Figure S2B.
(F) Representative EM images of wild-type cryopyrin (left), A439V-transduced (middle), and
staurosporine-treated (right) THP-1 cells. A439V-transduced cells demonstrate necrotic
features, including (1) degradation of the plasma membrane, (2) dysmorphic/swollen
mitochondria, and (3) the lack of chromatin condensation. Staurosporine-treated cells exhibit
a typical apoptotic morphology.
All values are the mean of three independent experiments. Error bars indicate standard
deviation of the mean.
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Figure 2. Disease-Associated CIAS1 Induces IL-1β Release, but Cell Death Is IL-1β Independent
(A) IL-1β is released from THP-1 cells infected with two mutant forms of CIAS1 as measured
by ELISA. IL-1β release is abrogated with 100 μM YVAD.
(B) IL-18 is released from THP-1 cells infected with two mutant forms of CIAS1 as measured
by ELISA. IL-18 release is abrogated with 100 μM YVAD.
(C) Cell death induced by CIAS1 mutants is not inhibited by 100 μM YVAD. Viability was
measured by XTT reduction 24 hr posttransduction.
(D) Kineret, the IL-1 receptor antagonist, does not prevent cryopyrin-induced cell death. THP-1
cells were infected with the indicated adenovirus for 24 hr in the presence or absence of Kineret.
NT, not treated with Kineret.
(E) IL-8 induction in THP-1 cells by recombinant IL-1β is inhibited by Kineret. IL-1β induced
a significant level of IL-8 production; this biologic effect of IL-1β was completely abrogated
by Kineret.
(F) Cell death induced by cryopyrin mutants is blocked by a cathepsin B inhibitor, Ca-074-
Me. THP-1 cells were infected with the indicated adenovirus for 24 hr in the presence or
absence of Ca-074-Me. Viability was measured by XTT reduction after 24 hr.
All values are the mean of three independent experiments. Error bars indicate standard
deviation of the mean.
Willingham et al. Page 16













Figure 3. Mutant-CIAS1-Induced THP-1 Cell Death Is ASC Dependent
(A and B) Expression of ASC is markedly decreased in cells stably transduced with shRNA
designed to promote the degradation of ASC mRNA (shASC). Immunoblot analysis and real-
time PCR of the indicated stable cell lines verify a decrease of ASC protein (A) and mRNA
(B).
(C) IL-1β release following infection with CIAS1-containing adenovirus is abrogated in cells
with shASC. IL-1β was determined by ELISA. Values < 10 pg/ml are considered not detectable
(“N/D”).
(D) Mutant CIAS1-induced cell death is abrogated in cells with decreased expression of ASC
caused by shASC. XTT reduction was measured 24 hr after adenoviral infection.
All values are the mean of three independent experiments. Error bars indicate standard
deviation of the mean.
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Figure 4. HMGB1 Is Released from THP-1 Cells Following Expression of Disease-Associated
CIAS1 Mutants
(A) Two disease-associated CIAS1 mutants induce substantially more HMGB1 release than
the wild-type gene.
(B) HMGB1 release is abrogated in cells with shASC, which reduced ASC expression.
(C) Inhibition of caspase-1 with YVAD-CHO does not substantially affect HMGB1 release.
Nitrocellulose membranes stained with amido black are provided as loading controls.
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Figure 5. Cell Death in Cells Isolated from FCAS Patients and in Cells Expressing Wild-Type
CIAS1
(A) Cell viability is decreased in PBMCs from FCAS patients in response to LPS. XTT
reduction was used to assay cell viability and was measured 72 hr after stimulation. *p < 0.05,
**p < 0.01 when compared to controls.
(B) Cell viability is diminished in THP-1 cells expressing wild-type CIAS1 at higher
multiplicities of infection. XTT reduction was measured 48 hr after adenoviral infection.
All values are the mean of three independent experiments. Error bars indicate standard
deviation of the mean.
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Figure 6. Shigella flexneri-Induced Cell Death and IL-1β Require CIAS1 and ASC but Not
Caspase-1
(A) Cryopyrin protein expression is decreased in THP-1 cells transduced with cryopyrin-
specific shRNA (shCIAS1).
(B) S. flexneri-induced IL-1β release is diminished in CIAS1-deficient THP1 cells.
(C) THP-1 cells with shCIAS1 resist S. flexneri-induced death but not staurosporine-induced
death.
(D and E) ASC is required for S. flexneri-induced cell death (D) and IL-1β release (E) in THP-1
cells.
(F) CIAS1−/− bone marrow-derived macrophages exhibit decreased levels of cell death in
response to S. flexneri.
(G) S. flexneri-induced IL-1β release from thioglycolate-elicited peritoneal macrophages is
reduced in CIAS1−/− macrophages.
(H) S. flexneri does not require Caspase-1 to initiate cell death.
(I) S. flexneri requires caspase-1 to induce IL-1β production in bone marrow-derived
macrophages.
(J) Cryopyrin initiates cell death in response to virulent Shigella. Bone marrow-derived
macrophages were infected with either 2457T (virulent) or BS103 (avirulent) S. flexneri at a
moi of 50 for 2 or 4 hr. Absence of virulence plasmid in BS103 was verified by ipaB
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immunoblot (inset). In all cases, cell death was measured by 7-aad uptake or LDH release and
IL-1β determined by ELISA.
All values are the mean of three independent experiments. Error bars indicate standard
deviation of the mean.
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Figure 7. Shigella flexneri Induces Cryopyrin-Dependent Necrosis
(A) Infection with S. flexneri for 6 hr induced cell death that is morphologically consistent with
necrosis (see Ai and Aii). To detect intracellular bacteria, a shorter infection time (2 hr) was
used so that the cells are just entering the initial phase of cell death. Cells with shCTRL, but
not shCIAS1, exhibited a lost of cytoplasmic content as determined by EM imaging. Insets
show the presence of bacteria (opaque round or oblong structures).
(B) PARP is not cleaved following S. flexneri infection.
(C) Cathepsin B inhibitor (50 μM) (Ca-074-Me) substantially abrogates S. flexneri cell death.
In contrast, 100 μM pan-caspase (zVAD-fmk) and 100 μM caspase-1 specific (YVAD-CHO)
inhibitors fail to block S. flexneri-induced cell death in shCTRL and shCIAS1 cells at 6 hr.
(D and E) S. flexneri-induced IL-1β (D) and IL-18 (E) release is reduced in shCIAS1 THP-1
cells and in cells treated with 100 μM YVAD-CHO.
(F) S. flexneri-induced HMGB1 release is abrogated by shCIAS1, and thus is cryopyrin
dependent. In all cases, cell death was measured by 7-aad uptake. IL-18 and IL-1β release were
determined by ELISA.
All values are the mean of three independent experiments. Error bars indicate standard
deviation of the mean.
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